Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
206 words
An N-benzoyl urea compound having the formula: ##STR30## wherein X is a hydrogen atom, a halogen atom or a nitro group, n is an integer of from 1 to 3, and Q is ##STR31## wherein Y 1 is alkyl, alkoxy or alkoxycarbonyl or said alkyl, said alkoxy or said alkoxycarbonyl substituted by at least one group selected from the group consisting of halogen, alkoxy, alkylthio, cyano and thiocyanate; Y 2 is hydrogen, halogen, nitro, alkyl, alkoxy or alkoxycarbonyl, or said alkyl, said alkoxy or said alkoxycarbonyl substituted by at least one group selected from the group consisting of halogen, alkoxy, alkylthio, cyano and thiocyanate; Z is hydrogen, halogen, trifluoromethyl or nitro, and each of A and B is ═CH-- or nitrogen, provided that one of A and B is ═C-- and the other is nitrogen, with the provisos (1) that when Q is ##STR32## where (ii) when X is hydrogen and Y l is alkyl, Z is not hydrogen, halogen or trifluoromethyl; and (2) that when Q is ##STR33## wherein A is nitrogen and Y l is trifluoromethyl, Y 2 is other than hydrogen and wherein the alkyl groups and the alkyl portions of said alkoxy and alkoxycarbonyl groups have from 1 to 6 carbon atoms.
Claim 2
Dependent Claim
206 words
An N-benzoyl urea compound having the formula: ##STR30## wherein X is a hydrogen atom, a halogen atom or a nitro group, n is an integer of from 1 to 3, and Q is ##STR31## wherein Y 1 is alkyl, alkoxy or alkoxycarbonyl or said alkyl, said alkoxy or said alkoxycarbonyl substituted by at least one group selected from the group consisting of halogen, alkoxy, alkylthio, cyano and thiocyanate; Y 2 is hydrogen, halogen, nitro, alkyl, alkoxy or alkoxycarbonyl, or said alkyl, said alkoxy or said alkoxycarbonyl substituted by at least one group selected from the group consisting of halogen, alkoxy, alkylthio, cyano and thiocyanate; Z is hydrogen, halogen, trifluoromethyl or nitro, and each of A and B is ═CH-- or nitrogen, provided that one of A and B is ═C-- and the other is nitrogen, with the provisos (1) that when Q is ##STR32## where (ii) when X is hydrogen and Y l is alkyl, Z is not hydrogen, halogen or trifluoromethyl; and (2) that when Q is ##STR33## wherein A is nitrogen and Y l is trifluoromethyl, Y 2 is other than hydrogen and wherein the alkyl groups and the alkyl portions of said alkoxy and alkoxycarbonyl groups have from 1 to 6 carbon atoms.
Claim 3
Dependent Claim
21 words
The N-benzoyl urea compound according to claim 1, wherein said C 1-6 group is methyl, ethyl, propyl, butyl, pentyl or hexyl.
Claim 4
Dependent Claim
12 words
The N-benzoyl urea compound according to claim 1, wherein Q is ##STR34##
Claim 5
Dependent Claim
31 words
The N-benzoyl urea compound according to claim 2, wherein X is nitro or halogen, Y 1 is alkyl or alkyl substituted by halogen, Y 2 is hydrogen, and Z is halogen.
Claim 6
Dependent Claim
12 words
The N-benzoyl urea compound according to claim 1, wherein Q is ##STR35##
Claim 7
Dependent Claim
28 words
The N-benzoyl urea compound according to claim 5, wherein Y 2 is alkyl or alkyl substituted by halogen, A is nitrogen, B is ═CH--, and Z is halogen.
Claim 8
Dependent Claim
9 words
The compound according to claim 3, which is N-(2-nitrobenzoyl)-N,-[4-(5-chloro-2-pyrimidinyloxy)-3-methylphenyl]urea.
Claim 9
Dependent Claim
9 words
The compound according to claim 3, which is N-(2-nitrobenzoyl)-N'-[4-(5-bromo-2-pyrimidinyloxy)-3-methylphenyl]urea.
Claim 10
Dependent Claim
9 words
The compound according to claim 5, which is N-(2-nitrobenzoyl)-N'-[4-(5-chloro-2-pyrimidinyloxy)-4-methylphenyl]urea.
Claim 11
Dependent Claim
39 words
An antitumorous composition which is effective against p-388 leukemia, L-1210 leukemia, B-16 melanoma, or M-5076 sarcoma in a mouse, comprising: a therapeutically effective amount of an N-benzoyl urea compound as defined in claim 1 and a pharmaceutically acceptable adjuvant.
Claim 12
Dependent Claim
38 words
A method for treating p-388 leukemia, L- 1210 leukemia, B-16 melanoma, or M-5076 sarcoma in a mouse, which comprises: administering a therapeutically effective amount of an N-benzoyl urea compound as defined in claim 1 to a diseased subject.